Multidrug-Resistant Hospital Bacteria: Epidemiological Factors and Susceptibility Profile

Marisa Castro Jara1,2, Andressa Vieira Frediani2, Fabiane Knepper Zehetmeyer1

  • 1Postgraduate Program in Biochemistry and Bioprospecting, Federal University of Pelotas, Pelotas, Brazil.

Microbial Drug Resistance (Larchmont, N.Y.)
|July 25, 2020
PubMed

Insights

Multidrug-resistant bacteria, particularly Klebsiella pneumoniae, are prevalent in Pelotas, Brazil. High resistance rates were observed in Gram-negative bacilli and Gram-positive cocci against common antibiotics, necessitating urgent antimicrobial stewardship.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Antimicrobial resistance (AMR) is a growing global health threat driven by microbial evolution and antibiotic misuse.
  • This study investigated the prevalence and resistance profiles of multidrug-resistant (MDR) bacteria in two hospitals in Pelotas, Brazil.

Discussion:

  • Klebsiella pneumoniae was the most frequently isolated bacterium, followed by Acinetobacter baumannii, Escherichia coli, and Pseudomonas aeruginosa among Gram-negative bacilli (GNB).
  • Enterococcus faecium and Staphylococcus aureus showed high resistance rates among Gram-positive cocci (GPC).
  • Significant resistance was noted for penicillins, quinolones, and cephalosporins against GNB, and macrolides, lincosamides, and penicillins against GPC.

Key Insights:

  • The study identified specific bacterial pathogens and their resistance patterns in a Brazilian hospital setting.
  • High rates of resistance to commonly prescribed antibiotics underscore the challenge of treating bacterial infections.
  • Polypeptides demonstrated high sensitivity against GNB, while fusidanes, glycylcyclines, and lipopeptides were effective against GPC.

Outlook:

  • Findings highlight the urgent need for enhanced infection control and antimicrobial stewardship programs in the region.
  • Further research is warranted to monitor resistance trends and inform treatment guidelines.
  • Development of novel antimicrobial agents and alternative therapies is crucial to combat MDR infections.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
911
Antibiotic Selection00:57

Antibiotic Selection

Overview
58.8K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.4K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
368